Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004583396 | SCV005064501 | likely pathogenic | Wilms tumor 1 | 2018-06-19 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Loss-of-function variants in GPC3 are known to be pathogenic (PMID: 12713262, 17603795). This variant has not been reported in the literature in individuals with GPC3-related disease. This variant results in a copy number gain of the genomic region encompassing exon 6 of the GPC3 gene. While the exact position of this variant cannot be determined from this data, sub-genic copy number gains are generally in tandem (PMID: 25640679) and may result in an absent or disrupted protein product. |